Recruiting

Eicosanoids

Sponsor:

Université de Sherbrooke

Code:

NCT00939744

Conditions

Obstetric Labor Complications

Prolonged Pregnancy

Eligibility Criteria

Sex: Female

Age: 18 - 40

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Recent studies show that EET and 20-HETE have important biological effects, particularly in the vascular system. The investigators studied the effect of eicosanoids on the gravid rat uterus. The results suggest that 20-HETE had an tocolytics effect on gravid uterus. In the previous study, we demonstrated that the enzymes of the pathway of EET were present in human uterine tissues. Moreover, the addition of an inhibitor of degradation of EET had an tocolytic effect on the human myometrium, as the exogenous addition of 8.9, 14,15-EET and 20-HETE.

Objectives:

Primary objective: To compare the balance of different metabolic pathways of arachidonic acid (AA) of the pregnant human myometrium in pathological situations (preterm labor, uterine atony, prolonged pregnancy).

Specific objectives: i) To study the effect of derived from the AA on in vitro contractile activity of normal and pathological uterine tissues, and ii) detect and quantify the different sub-products of metabolism of AA in the uterine tissues (myometrium, fetal membranes and placenta).

The management of uterine contraction is in the heart of modern obstetrics year, yet the progress made in other specialties, based on the study of smooth muscle have not yet been transposed in obstetrics. A better understanding of systems for regulating the contraction is important in terms of 1) new physiological knowledge, but it could also be the source of 2) modification of strategies to take care of premature delivery (new Tocolytic), or 3) improving the efficiency of uterine muscle during delivery or 4) for treatment of patients with prolonged pregnancy.

Conditions

Obstetric Labor Complications

Prolonged Pregnancy

Study ID

NCT00939744

Start date

May, 2009

Status verified date

Mar, 2015

Completion date

Oct, 2015

Anticipated

Primary completion date

Jul, 2015

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18 - 40

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • all women who will have a c-section

Exclusion Criteria:

  • induction of labor,
  • child with malformation,
  • birth weight less than 2500 grams or greater than 4500g

Study Design

Enrollment

130 participants

Anticipated

Interventions and Outcome Measures

Arms

EAU2

Women who will have a c-section at the CHUS

Primary outcome measure

  • effect of eicosanoids on contractile activity of myometrium of pregnant women with pathological situations [ Time Frame: during c-section ]

Central Contacts and Locations

Locations

Centre hospitalier de l'Université de Sherbrooke

Recruiting

Sherbrooke, Quebec, Canada, J1H 5N4

More Information

Sponsor

Université de Sherbrooke

Last update posted

Mar 4, 2015

Last verified

Mar, 2015

Keywords

  • contractile activity
  • eicosanoids
  • pregnant women
  • obstetrics complications

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Université de Sherbrooke on 2015-03-04.